Skip to main content

Table 2. Patient laboratory data

From: Efficacy of denosumab therapy for a 12-year-old female patient with Williams syndrome with osteoporosis and history of fractures: a case report

 

Before

1 month

2 months

5 months

9 months

11 months

17 months

23 months

29 months

Alb-corrected Ca

9.4

9.5

11.0

9.6

10.0

9.8

9.6

10.4

10.6

P

4.3

3.5

4.5

4.3

3.9

3.7

4.0

4.2

3.4

BAP

38.2

44.9

36.7

44.9

20.9

35.2

30.0

18.8

23.0

PINP

404

392

286

406

341

473

374

183

230

NTX

73.5

87.6

148

322

220

282

233

1596

1276

TRACP-5b

692

353

579

1290

652

1190

997

660

939

1,25(OH)2D

188

155

103

66.7

73.3

64.1

59.6

53.0

41.8

25(OH)D

13.7

N/A

N/A

20.8

22.8

25.4

24.3

20.5

20.0

Whole PTH

7.4

9.0

7.8

6.4

5.3

5.9

5.0

4.1

4.0

  1. Alb-corrected Ca albumin-corrected calcium, P phosphorus, BAP bone-specific alkaline phosphatase, PINP type I procollagen N-terminal propeptide, NTX type I collagen amino-terminal telopeptide, TRACP-5b tartrate-resistant acid phosphatase 5b, 1,25(OH)2D 1-α, 25-dihydroxyvitamin D3, 25(OH)D 25-hydroxyvitamin D3, PTH parathyroid hormone